<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Topical antimicrobial agents used for burns&lt;sup&gt;[1,2]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Topical antimicrobial agents used for burns<sup>[1,2]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Topical antimicrobial agents used for burns<sup>[1,2]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Antimicrobial agents</td> <td class="subtitle1">Clinical indications</td> <td class="subtitle1">Effectiveness</td> <td class="subtitle1">Contraindications</td> <td class="subtitle1">Adverse effects</td> </tr> <tr class="divider_bottom"> <td>Silver sulfadiazine (1% cream) with or without cerium</td> <td>Small, medium, and large surface area burns</td> <td> <p>Decreased colonization of wounds</p> <p>Alleviates pain</p> <p>Broad spectrum</p> No evidence to support improved wound healing or reduction in bacterial wound <span style="white-space: nowrap;">infections<sup>[3]</sup></span></td> <td> <p>Burns near eyes</p> <p>Pregnancy</p> <p>Breastfeeding</p> <p>Newborns &lt;2 months</p> <p>Allergic to sulfonamides</p> Signs of reepithelialization</td> <td> <p>Skin hypersensitivity</p> <p>Neutropenia (usually transient)</p> <p>Leukopenia (usually transient)</p> Methemoglobinemia</td> </tr> <tr class="divider_bottom"> <td>Silver containing dressings (eg, Acticoat, Aquacel Ag)</td> <td>Small, medium, and large surface area burns</td> <td>Stronger antimicrobial activity, longer duration of action than silver sulfadiazine, some evidence for reduced wound infection <span style="white-space: nowrap;">rates<sup>[3]</sup></span></td> <td> <p>Burns near eyes</p> <p>Pregnancy</p> Allergic to silver</td> <td>Systemic silver uptake, temporary staining of the skin, <span style="white-space: nowrap;">argyrosis-argyria*<sup>[4,5]</sup></span></td> </tr> <tr class="divider_bottom"> <td> <p>Bacitracin ointment</p> 500 units/gram</td> <td> <p>Small surface area burns</p> <p>Face</p> <p>Ears</p> <p>Perineum</p> <p>Graft sites</p> Alternative if allergic to sulfonamides</td> <td> <p>Ease of application and of removal</p> <p>Painless</p> Frequent dressing changes</td> <td> <p>Bacterial resistance</p> Signs of reepithelialization</td> <td> <p>Yeast colonization</p> Skin hypersensitivity</td> </tr> <tr class="divider_bottom"> <td>Combination antibiotic ointment (eg, bacitracin, neomycin, and polymyxin B)</td> <td> <p>Small surface area burns</p> <p>Face</p> <p>Ears</p> <p>Perineum</p> <p>Graft sites</p> Alternative if allergic to sulfonamides</td> <td> <p>Ease of application and of removal</p> <p>Painless</p> Frequent dressing changes</td> <td> <p>Bacterial resistance</p> <p>Allergic reaction</p> Signs of reepithelialization</td> <td> <p>Yeast colonization</p> <p>Skin hypersensitivity</p> Ototoxicity and nephrotoxicity with neomycin-containing ointments (eg, Neosporin)</td> </tr> <tr class="divider_bottom"> <td>Mupirocin ointment/cream 2%</td> <td> <p>Small, medium surface area burns</p> <p>Face</p> <p>Ears</p> <p>Nose</p> <p>Perineum</p> Alternative if allergic to sulfonamides</td> <td> <p>Gram-positive coverage includes methicillin-resistant <em>Staphylococcus aureus</em> (MRSA)</p> <p>Ease of application and of removal</p> <p>Painless</p> Frequent dressing changes</td> <td> <p>Bacterial resistance</p> <p>Allergic reaction</p> Signs of reepithelialization</td> <td> <p>Yeast colonization</p> Skin hypersensitivity</td> </tr> <tr class="divider_bottom"> <td>Mafenide (8.5% cream, 5% solution)</td> <td> <p>Ears</p> <p>Nose</p> Dense bacterial proliferation</td> <td> <p>Excellent eschar penetration</p> <p>Penetrates cartilage</p> Gram-negative coverage includes <em>Pseudomonas</em></td> <td> <p>Burns &gt;40% total body surface area</p> Allergic to sulfonamides</td> <td> <p>Metabolic acidosis (inhibits carbonic anhydrase)</p> <p>Painful</p> Inhibits epithelial regeneration</td> </tr> <tr class="divider_bottom"> <td>Chlorhexidine</td> <td>Only superficial burns</td> <td> <p>Does not interfere with reepithelialization</p> <p>Can be used with silver sulfadiazine</p> Generally used as a cleansing agent</td> <td> <p>Deep burns</p> Caution in neonates â€“ rare association with cutaneous burns</td> <td>Skin hypersensitivity</td> </tr> <tr class="divider_bottom"> <td>Povidone-iodine</td> <td>Small, medium surface area burns</td> <td>Only when no other agent is available</td> <td> <p>Children under 2 years</p> <p>Pregnancy</p> <p>Breastfeeding</p> <p>Thyroid disorders</p> Signs of reepithelialization</td> <td> <p>Cytotoxicity (toxic to fibroblasts, reduces cell proliferation)</p> <p>Painful</p> <p>Skin hypersensitivities</p> <p>Chemical burn</p> <p>Iodine toxicity</p> <p>Renal failure</p> <p>Acidosis</p> Anaphylaxis</td> </tr> <tr> <td>Acetic acid</td> <td>Antiseptic, topical agent often used in a diluted form as an adjunct in the setting of <em>Pseudomonas aeruginosa</em><span style="white-space: nowrap;"><sup>[6]</sup></span></td> <td>Gram-negative bacteria including <span style="white-space: nowrap;"><em>P. aeruginosa</em><sup>[7]</sup></span></td> <td>Superficial burns have been described from <span style="white-space: nowrap;">misuse<sup>[8]</sup></span></td> <td>High concentrations inhibit epithelialization, inhibit PMNs and fibroblasts</td> </tr> </tbody></table></div><div class="graphic_lgnd">Topical antimicrobial agents may increase risk of host fungal infections. Nystatin ointment or powder may be useful in combination with topical antimicrobials to decrease fungal colonization.</div><div class="graphic_footnotes">PMNs: polymorphonucleocytes.<br/>* Blue-grey discoloration of tissues due to deposition of silver.</div><div class="graphic_reference">References:

<ol>
<li>Gauglitz GG. Treatment of infection in burns. In: Handbook of Burns, Jeschke MG (Ed), Springer-Verlag, New York 2012. Vol 1: Acute Burn Care.</li>
<li>Norman G, Christie J, Liu Z, et al. Antiseptics for burns. Cochrane Database Syst Rev 2017; 7:CD011821.</li>
<li>Nherera LM, Trueman P, Roberts CD, Berg L. A systematic review and meta-analysis of clinical outcomes associated with nanocrystalline silver use compared to alternative silver delivery systems in the management of superficial and deep partial thickness burns. Burns 2017; 43:939.</li>
<li>Wang XQ, Chang HE, Francis R, et al. Silver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressing. J Cutan Pathol 2009; 36:788.</li>
<li>Trop M, Novak M, Rodl S, et al. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006; 60:648.</li>
<li>Ryssel H, Kloeters O, Germann G, et al. The antimicrobial effect of acetic acid--an alternative to common local antiseptics? Burns 2009; 35:695.</li>
<li>Coban YK. Superficial burns secondary to misuse of acetic acid solution. J Burn Care Res 2007; 28:359.</li>
<li>Nagoba BS, Selkar SP, Wadher BJ, Gandhi RC. Acetic acid treatment of pseudomonal wound infections--a review. J Infect Public Health 2013; 6:410.</li>
</ol></div><div id="graphicVersion">Graphic 81801 Version 16.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
